Intestinal Microbiota Shifts towards Elevated Commensal Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in Mice

Background The zoonotic pathogen Campylobacter jejuni is a leading cause of bacterial foodborne enterocolitis in humans worldwide. The understanding of immunopathology underlying human campylobacteriosis is hampered by the fact that mice display strong colonization resistance against the pathogen due to their host specific gut microbiota composition. Methodology/Principal Findings Since the microbiota composition changes significantly during intestinal inflammation we dissected factors contributing to colonization resistance against C. jejuni in murine ileitis, colitis and in infant mice. In contrast to healthy animals C. jejuni could stably colonize mice suffering from intestinal inflammation. Strikingly, in mice with Toxoplasma gondii-induced acute ileitis, C. jejuni disseminated to mesenteric lymphnodes, spleen, liver, kidney, and blood. In infant mice C. jejuni infection induced enterocolitis. Mice suffering from intestinal inflammation and C. jejuni susceptible infant mice displayed characteristical microbiota shifts dominated by increased numbers of commensal Escherichia coli. To further dissect the pivotal role of those distinct microbiota shifts in abrogating colonization resistance, we investigated C. jejuni infection in healthy adult mice in which the microbiota was artificially modified by feeding live commensal E. coli. Strikingly, in animals harboring supra-physiological intestinal E. coli loads, colonization resistance was significantly diminished and C. jejuni infection induced enterocolitis mimicking key features of human campylobacteriosis. Conclusion/Significance Murine colonization resistance against C. jejuni is abrogated by changes in the microbiota composition towards elevated E. coli loads during intestinal inflammation as well as in infant mice. Intestinal inflammation and microbiota shifts thus represent potential risk factors for C. jejuni infection. Corresponding interplays between C. jejuni and microbiota might occur in human campylobacteriosis. Murine models introduced here mimick key features of human campylobacteriosis and allow for further analysis of immunological and molecular mechanisms of C. jejuni – host interactions.

[1]  U. Göbel,et al.  Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. , 2012, European journal of microbiology & immunology.

[2]  F. Haesebrouck,et al.  Poultry as a host for the zoonotic pathogen Campylobacter jejuni. , 2012, Vector borne and zoonotic diseases.

[3]  Si Ming Man.  The clinical importance of emerging Campylobacter species , 2011, Nature Reviews Gastroenterology &Hepatology.

[4]  S. Riordan,et al.  Prevalence of Campylobacter Species in Adult Crohn's Disease and the Preferential Colonization Sites of Campylobacter Species in the Human Intestine , 2011, PloS one.

[5]  U. Göbel,et al.  What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. , 2011, European journal of microbiology & immunology.

[6]  U. Göbel,et al.  Novel Murine Infection Models Provide Deep Insights into the “Ménage à Trois” of Campylobacter jejuni, Microbiota and Host Innate Immunity , 2011, PloS one.

[7]  D. Haller,et al.  Intestinal steroid profiles and microbiota composition in colitic mice , 2011, Gut microbes.

[8]  Si Ming Man,et al.  The role of bacteria and pattern-recognition receptors in Crohn's disease , 2011, Nature Reviews Gastroenterology &Hepatology.

[9]  Si Ming Man,et al.  The role of bacteria and pattern-recognition receptors in Crohn's disease , 2011, Nature Reviews Gastroenterology &Hepatology.

[10]  Wolf-Dietrich Hardt,et al.  Mechanisms controlling pathogen colonization of the gut. , 2011, Current opinion in microbiology.

[11]  K. T. Jørgensen,et al.  Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease , 2010, Gut.

[12]  U. Göbel,et al.  Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation , 2010, PloS one.

[13]  J. Lane,et al.  The food glycome: a source of protection against pathogen colonization in the gastrointestinal tract. , 2010, International journal of food microbiology.

[14]  E. Thiel,et al.  MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease , 2010, Gut.

[15]  Si Ming Man,et al.  Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease , 2010, Inflammatory bowel diseases.

[16]  U. Groß,et al.  Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. , 2010, International journal of medical microbiology : IJMM.

[17]  S. Duncan,et al.  The Induction of Colitis and Ileitis in Mice Is Associated with Marked Increases in Intestinal Concentrations of Stimulants of TLRs 2, 4, and 5 , 2010, PloS one.

[18]  C. von Mering,et al.  Like Will to Like: Abundances of Closely Related Species Can Predict Susceptibility to Intestinal Colonization by Pathogenic and Commensal Bacteria , 2010, PLoS pathogens.

[19]  C. Loddenkemper,et al.  Interleukin (IL)-23 mediates Toxoplasma gondii–induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17 , 2009, The Journal of experimental medicine.

[20]  K. Gradel,et al.  Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. , 2009, Gastroenterology.

[21]  C. Szymanski,et al.  Campylobacter sugars sticking out. , 2008, Trends in microbiology.

[22]  B. Wren,et al.  The second century of Campylobacter research: recent advances, new opportunities and old problems , 2007, Current opinion in infectious diseases.

[23]  V. DiRita,et al.  Campylobacter jejuni: molecular biology and pathogenesis , 2007, Nature Reviews Microbiology.

[24]  G. Dougan,et al.  Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota , 2007, PLoS biology.

[25]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[26]  U. Göbel,et al.  Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 , 2007, PloS one.

[27]  U. Göbel,et al.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli , 2007, Gut.

[28]  U. Göbel,et al.  Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii1 , 2006, The Journal of Immunology.

[29]  John E. Linz,et al.  C57BL/6 and Congenic Interleukin-10-Deficient Mice Can Serve as Models of Campylobacter jejuni Colonization and Enteritis , 2006, Infection and Immunity.

[30]  J. Panés,et al.  Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. , 2006, Gastroenterology.

[31]  K. Mølbak,et al.  Foodborne bacterial infection and hospitalization: a registry-based study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[33]  J. Butzler,et al.  Campylobacter, from obscurity to celebrity. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  G. Fantuzzi,et al.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production , 2001 .

[35]  B. Allos.  Association between Campylobacter infection and Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[36]  M. Hänninen.  Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni , 1990, Epidemiology and Infection.

[37]  M. Hänninen.  Effect of endotoxin on colonisation of Campylobacter jejuni in infant mice. , 1989, Journal of Medical Microbiology.

[38]  J. Dolby,et al.  The mechanism of protection of infant mice from intestinal colonisation with Campylobacter jejuni. , 1987, Journal of medical microbiology.

[39]  E. Balish,et al.  Immune response of athymic and euthymic germfree mice to Campylobacter spp , 1986, Infection and immunity.

[40]  S. Payne,et al.  Influence of iron on growth, morphology, outer membrane protein composition, and synthesis of siderophores in Campylobacter jejuni , 1986, Infection and immunity.

[41]  E. Balish,et al.  Pathogenesis of Campylobacter spp. in athymic and euthymic germfree mice , 1986, Infection and immunity.

[42]  E. Balish,et al.  Colonization and infection of athymic and euthymic germfree mice by Campylobacter jejuni and Campylobacter fetus subsp. fetus , 1986, Infection and immunity.

[43]  G. Ruiz-Palacios,et al.  Pathophysiology of Campylobacter enteritis. , 1986, Microbiological reviews.

[44]  J. Lindeman,et al.  Campylobacter colitis: histological immunohistochemical and ultrastructural findings. , 1985, Gut.

[45]  L. H. Field,et al.  Intestinal colonization of neonatal animals by Campylobacter fetus subsp. jejuni , 1981, Infection and immunity.

[46]  A. Buret,et al.  A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[47]  D. Katzka.  Incidence and Epidemiology of Irritable Bowel Syndrome After a Large Waterborne Outbreak of Bacterial Dysentery , 2007 .

[48]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.

[49]  G. Fantuzzi,et al.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[50]  J. Ketley.  Pathogenesis of enteric infection by Campylobacter. , 1997, Microbiology.

[51]  G. Hasçelik,et al.  Colonization of infant mice with flagellar variants of Campylobacter jejuni. , 1992, Acta microbiologica Hungarica.

[52]  Billy,et al.  [Campylobacter jejuni]. , 1989, Tijdschrift voor diergeneeskunde.